Increasing Knowledge of HIV Infection Status through Opt-Out TestingOpt-Out HIV Testing

被引：0
作者：
Harold W. Jaffe
机构：
[1] University of Oxford,Department of Public Health
来源：
Journal of Bioethical Inquiry | 2009年 / 6卷
关键词：
HIV; Diagnosis; Bioethics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The diagnosis of HIV infection is the point of entry for treatment and prevention services, yet many infected persons in both developed and developing countries remain undiagnosed. To reduce the number of undiagnosed infections, a variety of expanded testing policies have been recommended, including opt-out testing. This testing model assumes that in populations of increased HIV prevalence, voluntary testing should be offered to all patients seen in healthcare settings and performed unless patients specifically decline. While this approach raises ethical issues concerning “voluntariness”, access to care, and stigma, the potential benefits of opt-out testing far outweigh its potential adverse effects.
引用
收藏
页码：229 / 233
页数：4
相关论文
共 38 条
[1]  
Bhaskaran K(2008)Changes in the risk of death after HIV seroconversion compared with mortality in the general population Journal of the American Medical Association 300 51-59
[2]  
Hamouda O(2006)Changing the paradigm for HIV testing—The end of exceptionalism The New England Journal of Medicine 355 647-649
[3]  
Sannes S(1985)Provisional Public Health Service inter-agency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome Morbidity and Mortality Weekly Report 34 75-78
[4]  
Boufassa F(2003)Advancing HIV prevention: New strategies for a changing epidemic—United States, 2003 Morbidity and Mortality Weekly Report 52 329-332
[5]  
Johnson AM(2006)Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings MMWR. Recommendations and Reports 55 1-17
[6]  
Lambert PC(2000)Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: A collaborative re-analysis Lancet 355 1131-1137
[7]  
Bayer R(1994)Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment The New England Journal of Medicine 331 1181-1187
[8]  
Fairchild AL(2008)HIV screening in health care settings. Public health and civil liberties in conflict Journal of the American Medical Association 296 2023-2025
[9]  
Connor EM(2009)Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model Lancet 373 48-57
[10]  
Sperling RS(2007)Time to move towards opt-out testing for HIV in the UK British Medical Journal 334 1352-1354
1234